Item 2.02 Results of Operations and Financial Condition.

On March 10, 2020, Principia Biopharma Inc. (the "Company") issued a press release announcing our financial results for the fourth quarter and full year ended December 31, 2019. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

All of the information furnished in this Item 2.02 and Exhibit 99.1 of this Current Report on Form 8-K shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, and shall not be incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.





Exhibit
Number                                   Description
99.1        Press Release issued by Principia Biopharma Inc. dated March 10, 2020.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses